Enanta Pharmaceuticals (ENTA) Return on Capital Employed [ROCE] (2013 - 2026)
Enanta Pharmaceuticals' Return on Capital Employed [ROCE] came in at -23.34% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 12.86 percentage points from -36.20% a year earlier but down 1.43 percentage points from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Return on Capital Employed [ROCE] was -30.47%, up 3.16 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of -21.49 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Capital Employed [ROCE] was -33.62% in FY2024 (+4.91 pp), -38.54% in FY2023 (-5.71 pp), -32.83% in FY2022 (-7.12 pp) and -25.70% in FY2021 (-16.73 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is -42.34% (fiscal Q2 2023) to -21.91% (fiscal Q2 2026).
- Year-over-year, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of +4.23 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q2 2026 (a gain of 13.32 percentage points), and the weakest in fiscal Q4 2021 (a drop of 18.06 percentage points).
- Business Quant data shows ENTA's Return on Capital Employed [ROCE] at -21.91% (Q2 2026), -28.06% (Q1 2026) and -35.22% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Enanta Pharmaceuticals | 377.40 Mn | -350.60 Mn | - | -23.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.34% |
| Mar 31, 2026 | -21.91% |
| Dec 31, 2025 | -28.06% |
| Sep 30, 2025 | -35.22% |
| Jun 30, 2025 | -36.20% |
| Mar 31, 2025 | -35.23% |
| Dec 31, 2024 | -35.19% |
| Sep 30, 2024 | -36.85% |
| Jun 30, 2024 | -35.31% |
| Mar 31, 2024 | -36.95% |
| Dec 31, 2023 | -37.10% |
| Sep 30, 2023 | -32.99% |
| Jun 30, 2023 | -38.88% |
| Mar 31, 2023 | -42.34% |
| Dec 31, 2022 | -36.47% |
| Sep 30, 2022 | -35.34% |
| Jun 30, 2022 | -34.99% |
| Mar 31, 2022 | -33.55% |
| Dec 31, 2021 | -31.78% |
| Sep 30, 2021 | -26.83% |
API Access
Enanta Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();